AYURVEDIC MANAGEMENT OF SUB-COJUNCTIVAL HAEMORRHAGE

EFFECT OF KSHOUDRADI ASCHYOTANA IN ARJUNA w.s.r.t SUB-CONJUNCTIVAL HAEMORRHAGE â??A RANDOMISED CONTROLLED CLINICAL TRIAL - KASCH

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037840

Enrollment

Registered

2021-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H113- Conjunctival hemorrhage

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Irrespective of occupation, ocular diseases like refractive error, cataract, squint eyes, chalazion, entropion, ectropion, trichiasis, distichiasis, poliosis. Idiopathic sub-conjunctival haemorrhages Traumatic sub-conjunctival haemorrhage without epithelial defect

Exclusion criteria

Exclusion criteria: Systemic disorders like DM, HTN, COPD, Renal pathologies Patients with iatrogenic sub-conjunctival haemorrhage (Post-operative) Vicarious bleeding associated with menstruation Patients with other common cause of red eye such as conjunctivitis, episcleritis and scleritis keratitis and corneal ulcer, iritis glaucoma and common condition such as dry eye and blepharitis were excluded

Design outcomes

Primary

Measure	Time frame
Kshaudraadi Aschyotana if proved effective will help in managing Arjuna (sub conjunctival haemorrhage)Timepoint: 5days	—

Secondary

Measure	Time frame
Kshaudradi Aschyotana may be effective in managing arjuna (sub conjunctival haemorrhageTimepoint: 5 days	—

Countries

India

Contacts

Public ContactDr Arunkumar Bapurao Biradar

KAHERSs Shri BM Kankanawadi Ayurveda Mahavidyalaya

arunkumar.biradar@gmail.com9964064955

Outcome results